Recurrent DVT and PE in Young Adults May Indicate an Underlying Cause – The Lancet Group
The Lancet Group shared a post on LinkedIn about a recent article by Fernando Javier Vazquez et al. published in The Lancet, adding:
” ‘Awareness of such rare but treatable conditions can improve outcomes.’
Deep vein thrombosis (DVT) and pulmonary embolism are uncommon in young adults without recognised risk factors, and recurrence should raise suspicion of overlooked underlying causes.
A recent Clinical Rounds article published in The Lancet explores the case of a 20-year-old athlete presenting with recurrent DVT and pulmonary embolism due to an uncommon cause.
Dr Chloe Wilson, Senior Editor at The Lancet, summarises the case and highlights key learnings for clinicians.”
Proceed to the video attached to the post.
Title: An uncommon cause of recurrent deep vein thrombosis and pulmonary embolism in a young athlete: an osteochondroma compressing the popliteal vein
Author: Fernando Javier Vazquez
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering